Aracari tests therapies on tissues it grows in its proprietary organ and tumor chips to better predict efficacy and safety.
These microfluidic, vascularized chips have been developed by Arcari's scientific founders over the last two decades. This powerful next-generation technology is accelerating development of immuno-oncological and other therapeutics for more optimal patient outcomes.
Resource type
Platform
Country
United States
Access requirements
Purchase